Shaping the World’s Health Agenda: UN High-Level Meeting on NCDs
This September an event will take place in New York that could define the world’s agenda for the coming decade. I refer, of course, to the high-level meeting of the…
Who’s Confused? Angry Patients or Physicians?
Radiology practices don’t like having angry patients, according to AuntMinnie: Patient dissatisfaction is a recurring problem for radiology administrators and imaging providers, and one that can cause disruption, thus wasting…
Continuous Blood Glucose Monitoring in Diabetes
One of the fundamental challenges in managing diabetes, especially insulin-dependent diabetes mellitus (or "juvenile onset" diabetes) is the lag between a sharp trend in blood glucose levels (up or down)…
Krugman, Ezra: Wrong About Texas Health Care
Texas has the highest percent of its population uninsured of any state in the nation. Why is that? According to Paul Krugman, this is because of the “state’s small government…
Cigarette Makers Sue the FDA Over New Labeling Rules
This is getting interesting so say the least with this lawsuit. The FDA cannot comment here but how this ends up with an interpretation will be one to watch. Granted…
Why Profit Is Our Best Friend
One reason why entrepreneurs do what they do is that they want to become rich. I don’t think that getting rich is the main motivation. The possibility of innovating in…
3 Steps Towards Adopting Electronic Health Records
EXCLUSIVE POST - There are a variety of forces driving us toward the adoption of electronic health records and the collection, transmission and analysis of data and information to improve…
Individual Mandate: Can PPACA Survive Without It?
Ever since the Patient Protection and Affordable Care Act (PPACA) was passed, opponents have looked for ways to overturn it in the court of law and the court of public…
Myth Busters #5: Hospital Rate Setting
With the repeal of the Health Planning Act in 1982, a lot of health policy wonks found themselves out of work. They had to come up with something new to…
NanoViricides Reports Positive Anti-viral Effect of HIV Drug
NanoViricides (OTCBB:NNVC) announced Monday that its anti-HIV drug candidate, HIVCide, achieved a positive, long-term effect with fewer and weaker doses than the traditional anti-retroviral combination therapy. In a recent study…
